NCT03253991 - A Study to Evaluate the Effectiveness and Safety of ExAblate MRgFUS on Essential Tremor | Biotech Hunter

Enrollment

154

Participants

Timeline

Start Date

November 17, 2014

Primary Completion Date

February 2, 2023

Study Completion Date

February 2, 2023

Conditions

Essential Tremor

Interventions

DEVICE

MRgFUS treatment

ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects

Trial Locations (11)

Chang Bing Show Chwan Memorial Hospital, Chang-hua

Chinese PLA General Hospital, Beijing

Henan Provincial People's Hospital, Zhengzhou

Shonan Fujisawa Tokushukai Hospital, Fujisawa

Ohanishi Noerological Center, Hyōgo

Sadamoto Hospital, Ehime

Hokkaido Ohno Memorial Hospital, Hokkaido

Hokuto, Hokkaido

Kumagaya General Hospital, Kumagaya

Department of Neurosurgery, Osaka University Hospital, Osaka

Tokyo Women's Medical University Hospital, Tokyo